Multivalent cyclic RGD ligands: Influence of linker lengths on receptor binding

Nuclear Medicine and Biology

Volumn 37, Issue 8, 2010, Pages 885-891

  Kubas, Holger ^a   Schäfer, Martin ^a   Bauder Wüst, Ulrike ^a   Eder, Matthias ^a   Oltmanns, Dörte ^a   Haberkorn, Uwe ^b   Mier, Walter ^b   Eisenhut, Michael ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

v 3 integrin; Angiogenesis; Linker length; Multivalency; Peptides

Indexed keywords

ADAMANTANE 1,3,5,7 TETRACARBOXYLIC ACID; ARGINYLGLYCYLASPARTIC ACID; ECHISTATIN; IODINE 124; MACROGOL; MOLECULAR SCAFFOLD; TEREPHTHALIC ACID; TETRACARBOXYLIC ACID; TRIMESIC ACID; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG INHIBITION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ISOTOPE LABELING; LIGAND BINDING; PROTEIN EXPRESSION; RADIOASSAY; RADIOCHEMISTRY;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION; HUMANS; INTEGRIN ALPHAVBETA3; LIGANDS; PEPTIDES, CYCLIC; POLYETHYLENE GLYCOLS; PROTEIN BINDING;

EID: 78049477288     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2010.06.005     Document Type: Article

References (19)

1. Nemeth J.A., Nakada M.T., Trikha M., Lang Z., Gordon M.S., Jayson G.C., et al. Alpha-v integrins as therapeutic targets in oncology. Cancer Invest 2007, 25:632-646.
2. Dechantsreiter M.A., Planker E., Mathä B., Lohof E., Hölzemann G., Jonczyk A., et al. N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists. J Med Chem 1999, 42:3033-3040.
3. Haubner R., Wester H.J., Reuning U., Senekowitsch-Schmidtke R., Diefenbach B., Kessler H., et al. Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting. J Nucl Med 1999, 40:1061-1071.
4. Poethko T., Schottelius M., Thumshirn G., Hersel U., Herz M., Henriksen G., et al. Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs. J Nucl Med 2004, 45:892-902.
5. Schottelius M., Laufer B., Kessler H., Wester H.J. Ligands for mapping alphavbeta3-integrin expression in vivo. Acc Chem Res 2009, 42:969-980.
6. Wester H.J., Kessler H. Molecular targeting with peptides or peptide-polymer conjugates: just a question of size?. J Nucl Med 2005, 46:1940-1945.
7. Wang J., Kim Y.S., Liu S. 99mTc-labeling of HYNIC-conjugated cyclic RGDfK dimer and tetramer using EDDA as coligand. Bioconjug Chem 2008, 19:634-642.
8. Li Z.B., Chen K., Chen X. (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression. Eur J Nucl Med Mol Imaging 2008, 35:1100-1108.
9. Rao J., Lahiri J., Isaacs L., Weis R.M., Whitesides G.M. A trivalent system from vancomycin. d-Ala-d-Ala with higher affinity than avidin-biotin. Science 1998, 280:708-711.
10. Kramer R.H., Karpen J.W. Spanning binding sites on allosteric proteins with polymer-linked ligand dimers. Nature 1998, 395:710-713.
11. Krishnamurthy V.M., Semetey V., Bracher P.J., Shen N., Whitesides G.M. Dependence of effective molarity on linker length for an intramolecular protein-ligand system. J Am Chem Soc 2007, 129:1312-1320.
12. Thumshirn G., Hersel U., Goodman S.L., Kessler H. Multimeric cyclic RGD peptides as potential tools for tumor targeting: solid-phase peptide synthesis and chemoselective oxime ligation. Chem Eur J 2003, 9:2717-2725.
13. Newkome G.R., Nayak A., Behera R.K., Moorefield C.N., Baker G.R. Cascade polymers: synthesis and characterization of four-directional spherical dendritic macromolecules based on adamantane. J Org Chem 1992, 57:358-362.
14. 64Cu-labeled tetrameric RGD peptide. J Nucl Med 2005, 46:1707-1718.
15. Munson P.J., Rodbard D. An exact correction to the "Cheng-Prusoff" correction. J Recept Res 1988, 8:533-546. Erratum in: J Recept Res 1989-90;9:511.
16. Kimura R.H., Cheng Z., Gambhir S.S., Cochran J.R. Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects. Cancer Res 2009, 69:2435-2442.
17. Vagner J., Xu L., Handl H.L., Josan J.S., Morse D.L., Mash E.A. Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin-4 and delta-opioid receptors. Angew Chem 2008, 120:1709-1712. Angew Chem Int Ed 2008;47:1685-8.
18. Arnold M., Cavalcanti-Adam E.A., Glass R., Blümmel J., Eck W., Kantlehner M., et al. Activation of integrin function by nanopatterned adhesive interfaces. Chem Phys Chem 2004, 5:383-388.
19. Humblet V., Misra P., Bhushan K.R., Nasr K., Ko Y.S., Tsukamoto T., et al. Multivalent scaffolds for affinity maturation of small molecule cell surface binders and their application to prostate tumor targeting. J Med Chem 2009, 52:544-550.